John N Eble

Author PubWeight™ 107.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013 3.68
2 Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 2004 2.22
3 Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007 2.20
4 OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004 1.99
5 Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004 1.85
6 Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008 1.64
7 Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res 2005 1.63
8 Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst 2009 1.59
9 Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 2004 1.53
10 Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer 2004 1.45
11 High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am J Pathol 2003 1.35
12 OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 2004 1.34
13 Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol 2002 1.31
14 TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am J Surg Pathol 2013 1.28
15 Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 2005 1.21
16 Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol 2010 1.19
17 Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005 1.19
18 Loss of 14-3-3sigma in prostate cancer and its precursors. Clin Cancer Res 2004 1.19
19 Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 2005 1.19
20 Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 2007 1.18
21 Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease. Lung Cancer 2008 1.17
22 Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer 2005 1.16
23 Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. J Urol 2006 1.15
24 Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: support for a clonal origin of myelolipomas. Am J Surg Pathol 2006 1.15
25 Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Mod Pathol 2006 1.15
26 Metastatic juxtaglomerular cell tumor in a 52-year-old man. Am J Surg Pathol 2004 1.14
27 Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma. Am J Surg Pathol 2007 1.13
28 Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol 2007 1.12
29 Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006 1.11
30 Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 2007 1.10
31 Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res 2007 1.09
32 Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol 2014 1.08
33 Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res 2007 1.08
34 Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 2003 1.07
35 Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer. Am J Clin Pathol 2003 1.06
36 Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol 2008 1.06
37 Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol 2006 1.05
38 Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma. Mod Pathol 2007 1.05
39 Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Mod Pathol 2005 1.05
40 TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 2008 1.05
41 Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 2007 1.05
42 Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 2005 1.03
43 Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol 2005 1.03
44 Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 2005 1.03
45 Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod Pathol 2003 1.00
46 PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clin Cancer Res 2004 1.00
47 Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol 2004 0.99
48 Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors. Mod Pathol 2004 0.99
49 Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis. Mod Pathol 2006 0.98
50 Nephroblastoma arising in a germ cell tumor of testicular origin. Am J Surg Pathol 2004 0.97
51 Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles. Am J Surg Pathol 2010 0.97
52 Schwannoma of the kidney. Mod Pathol 2008 0.96
53 Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol 2003 0.96
54 p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol 2012 0.95
55 Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol 2014 0.94
56 c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol 2005 0.92
57 Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis. Am J Pathol 2003 0.90
58 Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Mod Pathol 2008 0.89
59 Renal disease in adults with TSC2/PKD1 contiguous gene syndrome. Am J Surg Pathol 2002 0.89
60 Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology. Cancer 2002 0.89
61 Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer 2002 0.89
62 Clonal origin of metastatic testicular teratomas. Clin Cancer Res 2006 0.89
63 Ectopic prostatic tissue: histogenesis and histopathological characteristics. Histopathology 2011 0.89
64 Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch Pathol Lab Med 2003 0.89
65 Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 2006 0.89
66 CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod Pathol 2004 0.88
67 Macroscopic sertoli cell nodule: a study of 6 cases that presented as testicular masses. Am J Surg Pathol 2010 0.87
68 Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin Lab Med 2005 0.87
69 Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod Pathol 2011 0.87
70 Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 2012 0.87
71 Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol 2012 0.87
72 Inverted papilloma of the urinary bladder: a molecular genetic appraisal. Mod Pathol 2006 0.87
73 Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. Anticancer Res 2004 0.87
74 Clonal origin of lymph node metastases in bladder carcinoma. Cancer 2005 0.87
75 Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod Pathol 2007 0.86
76 Bladder neck invasion is an independent predictor of prostate-specific antigen recurrence. Cancer 2004 0.86
77 Down-regulation of fragile histidine triad expression in prostate carcinoma. Cancer 2003 0.86
78 Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma. Cancer Res 2003 0.86
79 Molecular evidence supporting the neoplastic nature of some epidermoid cysts of the testis. Arch Pathol Lab Med 2003 0.86
80 Pleomorphic giant cell carcinoma of the prostate. Arch Pathol Lab Med 2005 0.85
81 Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens. Cancer 2003 0.85
82 Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. J Urol 2005 0.84
83 Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer. Prostate 2010 0.84
84 Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis. Mod Pathol 2008 0.83
85 Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma. Am J Surg Pathol 2013 0.83
86 Molecular genetic evidence supporting the neoplastic nature of fibrous stroma in testicular teratoma. Mod Pathol 2012 0.82
87 Nephrogenic adenomas in pediatric patients: a morphologic and immunohistochemical study of 21 cases. Pediatr Dev Pathol 2013 0.82
88 Novel markers of squamous differentiation in the urinary bladder. Hum Pathol 2013 0.82
89 Dendritic cells transfected with interleukin-12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo. Prostate 2003 0.81
90 Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol 2013 0.81
91 Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell. Am J Surg Pathol 2012 0.81
92 Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases. Arch Pathol Lab Med 2002 0.81
93 Mixed epithelial and stromal tumors of the kidney: evidence for a single cell of origin with capacity for epithelial and stromal differentiation. Am J Surg Pathol 2011 0.80
94 Signet ring cell carcinoma of the testis: clinicopathologic and molecular evidence for germ cell tumor origin--a case report. Am J Surg Pathol 2012 0.80
95 Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Cancer 2002 0.78
96 Cytokeratin and CD30 expression in dysgerminoma. Hum Pathol 2006 0.78
97 P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 2005 0.78
98 Re: A. Rose Brannon, Scott M. Haake, Kathryn E. Hacker, et al. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol 2012;61:258-68. Eur Urol 2012 0.78
99 Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases. Am J Surg Pathol 2016 0.77
100 Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases. Am J Surg Pathol 2016 0.77
101 Cystic partially regressed clear cell renal cell carcinoma: a potential mimic of multilocular cystic renal cell carcinoma. Histopathology 2013 0.77
102 Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors. Int J Gynecol Pathol 2007 0.76
103 Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis. Am J Surg Pathol 2015 0.76
104 History of the development of the classification of renal cell neoplasia. Clin Lab Med 2005 0.75
105 Clonal evidence for the progression of a testicular germ cell tumor to angiosarcoma. Hum Pathol 2010 0.75
106 Invasion of fat justifies assignment of stage pT3a in prostatic adenocarcinoma. Pathology 2006 0.75
107 Pure cartilaginous teratoma of the testis: an immunohistochemistry and fluorescence in situ hybridisation study. J Clin Pathol 2007 0.75
108 Relative promoter strengths in four human prostate cancer cell lines evaluated by particle bombardment-mediated gene transfer. Prostate 2002 0.75
109 Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms. Am J Surg Pathol 2016 0.75
110 Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma. Anal Quant Cytol Histol 2009 0.75
111 Renal cell neoplasia. Pathology 2002 0.75
112 Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system. Prostate 2002 0.75
113 FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma. Anticancer Res 2011 0.75
114 Renomedullary Interstitial Cell Tumors: Pathologic Features and Clinical Correlations. Am J Surg Pathol 2016 0.75
115 Bilateral ovarian steroid cell tumours and massive macronodular adrenocortical disease in a patient with hereditary leiomyomatosis and renal cell cancer syndrome. Pathology 2012 0.75